CLINICAL_TRIALS
trial_result
· 2016-05-27
Clinical Trial Update: A Phase 3 Study in Participants With Moderate to Severe Psoriasis [Phase 3]
Summary
Phase 3 study in adults with moderate to severe psoriasis has completed and results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2016-05-27